Skip to content

News

Highlights: 2021 Virtual Annual Meeting of the Society of Gynecologic Oncology (SGO)

Highlights: 2021 Virtual Annual Meeting of the Society of Gynecologic Oncology (SGO)

2021 SGO Virtual Meeting Themes This year’s Society of Gynecologic Oncology annual meeting was held virtually, with most sessions held March 19 to 21, 2021. The majority of sessions included pre-recorded abstract presentations followed by dynamic and engaging live Q&A. In addition to the latest research in gynecologic cancers highlighted below, several sessions included timely … Continued

The Overview: April 2021

The Overview: April 2021

Flowers are blooming all around us, people are beginning to rediscover the things that matter most, and every day, OCRA grantees are making strides in understanding even more about ovarian cancer. Happy (almost!) May! RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS TO GIVE

OCRA Co-Signs Letter to President Biden Supporting HARPA

OCRA Co-Signs Letter to President Biden Supporting HARPA

On April 9, President Biden released his discretionary funding request for fiscal year 2022. Within the request, the President announced the creation of an agency that would take on high-risk, high-reward health research seeking to advance medical technologies. The agency is modeled after the renowned Defense Advanced Research Projects Agency (DARPA) which leverages public investments … Continued

Celebrating Real-Life Heroes for National Superhero Day

Celebrating Real-Life Heroes for National Superhero Day

National Superhero Day may bring to mind fictional characters swooping in to the save the day with feats of strength, but here at Ovarian Cancer Research Alliance, we celebrate the real-life OCRA Heroes who are doing their part to save lives in our community.    The below heroes may not possess superhuman strength, powers of invisibility … Continued

Raising Awareness of a Silent Epidemic | Survivor Stories

Raising Awareness of a Silent Epidemic | Survivor Stories

Janice Murphy is a woman with many passions: sharing her love of the Great American Songbook, living life to the fullest — and making sure healthcare providers know that ovarian cancer may pose a greater risk for older lesbian women. Janice was 62 years old and newly married to a woman she had been committed … Continued

Rare Ovarian Cancers: Research Updates

Rare Ovarian Cancers: Research Updates

Every year, more than 22,000 people are diagnosed with ovarian cancer. Most (85% – 90%) will be diagnosed with a form of epithelial ovarian cancer; and among these, most will be high-grade serous ovarian cancer (HGSOC). Though HGSOC is the most common type of ovarian cancer, there are several different types and subtypes of the … Continued

Vulnerability in ARID1A-Mutant Cancer Cells Could Provide New Pathways for OCCC Treatment

Vulnerability in ARID1A-Mutant Cancer Cells Could Provide New Pathways for OCCC Treatment

OCRA grantees Dr. Rugang Zhang and Dr. Shuai Wu, both of The Wistar Institute, along with colleagues, have discovered a vulnerability in cancer cells that harbor certain genetic mutations. Their findings, which involve the ARID1A gene, point to potential new pathways of treatment for patients living with ovarian clear cell carcinoma (OCCC). What is an ARID1A mutation?   ARID1A … Continued

Egg Freezing for Ovarian Cancer Patients

Egg Freezing for Ovarian Cancer Patients

Fertility preservation is an important consideration for many young ovarian cancer patients and one common procedure is egg freezing. Here are common questions and considerations to take into account while making those decisions.  What is Egg Freezing? To start, the scientific name for a woman’s egg is called an oocyte. At birth, a woman has … Continued

Urgent: Tell Your U.S. Representative to Support a $10 Million Increase to OCRP

Urgent: Tell Your U.S. Representative to Support a $10 Million Increase to OCRP

On Friday, March 19, U.S. House Representatives Grace Meng (D-NY), Brian Fitzpatrick (R-PA), and Norma Torres (D-CA) released a bipartisan “Dear Colleague” letter urging the House Appropriations Defense Subcommittee to fund the Ovarian Cancer Research Program (OCRP) at $45 million for Fiscal Year 2022, an increase of $10 million over last year.  OCRP is the only federally-funded … Continued

The Overview: March 2021

The Overview: March 2021

The snow is (finally!) melting in the areas where many of us at OCRA work and live, the COVID vaccine is rolling out, and there is so much work being done to improve the lives of the ovarian cancer community … we can’t help but feel hopeful. Read on to discover the latest, and perhaps … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.